Dr. Dubé is a senior socio-behavioral scientist and experienced research program manager who integrates biomedical, social sciences, ethics and patient engagement around HIV-related research in the United States and South Africa. She has close to 20 years of experience in infectious disease-related work, including the socio-behavioral sciences and ethics of HIV cure-related research, HIV prevention, HIV treatment, Ebola, malaria and HSV-2.
She is the Multi-Principal Investigator of a National Institute of Mental Health (NIMH) R01 grant investigating psychosocial experiences of people with HIV who interrupt treatment during cure research as part of the AIDS Clinical Trials Group (ACTG) and at the University of California San Francisco (UCSF) (with Dr. John Sauceda, UCSF). She completed a R21-NIMH grant (as Principal Investigator/Project Director) that integrated participant-centered outcomes and socio-behavioral assessments in clinical trials in the ACTG. She is the lead socio-behavioral researcher and bioethicist on the University of California San Diego (UCSD) Last Gift program (http://lastgift.ucsd.edu/). She also consults for and has consulted with several groups on socio-behavioral sciences related to HIV cure research, notably the BEAT-HIV Collaboratory (Wistar Institute), RID-HIV Collaboratory (Scripps Research Institute), the amfAR Institute for HIV Cure Research and Delaney AIDS Research Enterprise (DARE) Collaboratory, the City of Hope/California Institute of Regenerative Medicine (CIRM), and the Ragon Institute of MGH, MIT and Harvard.
Dr. Dubé served as Co-Investigator on the Social and Ethical Aspects of Curing HIV Infection (searcHIV) working group at UNC Chapel Hill from 2014 – 2017. She also served as Research Program Manager for the Collaboratory of AIDS Researchers for Eradication (CARE) at UNC-Chapel Hill from 2013 – 2015. She led willingness to participate research in HIV cure in the United States. She is co-founder and co-leader of the CUREiculum (https://www.treatmentactiongroup.org/cure/cureiculum-2-0/), a collaborative program aimed at making HIV cure science accessible to the community and the HIV research field.
In 2016, she managed the UNC-CH – ClinicalRM – ELWA Ebola consortium. She led a vaccine cohort development program, two HIV-1C prospective incidence studies and a clinical research site capacity development effort in Maputo, Beira and Chókwè, Mozambique with the United States Military HIV Research Program (MHRP)/Walter Reed Army Institute of Research/Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) and FHI 360.